Skip to main content

Cyclo Therapeutics Inc. Common Stock (CYTH)

About The Company

CYTH Stock Market Logo

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.

IPO Year Sector Industry
N/A Health Care Biotechnology: Pharmaceutical Preparations

Cyclo Therapeutics Inc. (CYTH) Latest News

Company Contact & Address (CYTH)

Corporate Headquarters Phone Website
United States
+1 386 418-8060 Official CYTH Website

CYTH Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ CYTH

Jobs & Employment at Cyclo Therapeutics Inc.

LinkedIn Company Page
Official Career & Employment Page View LinkedIn page for more jobs & employment details.

Related & Similar Stock Symbols

ERIE Stock Market Price & News


Erie Indemnity Company Class A Common Stock

WSO Stock Market Price & News


Watsco Inc. Common Stock

SNAP Stock Market Price & News


Snap Inc. Class A Common Stock